
Burning Rock Biotech Limited BNR
$ 23.2
-1.44%
Annual report 2021
added 12-23-2023
Burning Rock Biotech Limited ROE Ratio 2011-2026 | BNR
Annual ROE Ratio Burning Rock Biotech Limited
| 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 |
|---|---|---|---|---|---|---|---|---|---|---|
| -43.17 | -16.82 | 18.97 | 29.41 | - | - | - | - | - | - | - |
All numbers in CNY currency
Indicator range from annual reports
| Maximum | Minimum | Average |
|---|---|---|
| 29.41 | -43.17 | -2.9 |
ROE Ratio of other stocks in the Diagnostics research industry
| Issuer | ROE Ratio | Price | % 24h | Market Cap | Country | |
|---|---|---|---|---|---|---|
|
Agilent Technologies
A
|
22.45 | $ 119.98 | 0.83 % | $ 36.5 B | ||
|
Anixa Biosciences
ANIX
|
-72.07 | $ 2.93 | 3.53 % | $ 95.1 K | ||
|
Centogene N.V.
CNTG
|
-170.35 | - | -6.23 % | $ 30.6 M | ||
|
Aspira Women's Health
AWH
|
-403.65 | - | -6.19 % | $ 10.5 M | ||
|
Celcuity
CELC
|
-96.68 | $ 106.88 | -0.49 % | $ 4.22 B | ||
|
Akumin
AKU
|
325.23 | - | -17.87 % | $ 25.9 M | ||
|
Castle Biosciences
CSTL
|
4.0 | $ 27.88 | 1.12 % | $ 774 M | ||
|
Oxford Immunotec Global PLC
OXFD
|
-0.85 | - | - | $ 562 M | ||
|
Heska Corporation
HSKA
|
-4.71 | - | - | $ 1.31 B | ||
|
HTG Molecular Diagnostics
HTGM
|
-400.51 | - | -20.0 % | $ 1.06 M | ||
|
Charles River Laboratories International
CRL
|
-4.56 | $ 177.64 | 1.03 % | $ 8.8 B | ||
|
Fulgent Genetics
FLGT
|
-3.77 | $ 13.72 | -0.54 % | $ 415 M | ||
|
Accelerate Diagnostics
AXDX
|
65.62 | - | -61.36 % | $ 2.46 M | ||
|
Global Cord Blood Corporation
CO
|
10.27 | - | - | $ 399 M | ||
|
Fluidigm Corporation
FLDM
|
-38.13 | - | 1.08 % | $ 308 M | ||
|
Genetic Technologies Limited
GENE
|
-43.4 | - | - | $ 7.1 B | ||
|
Genetron Holdings Limited
GTH
|
-181.33 | - | 0.12 % | $ 80.1 M | ||
|
PRA Health Sciences, Inc.
PRAH
|
13.32 | - | - | $ 10.7 B | ||
|
Motus GI Holdings
MOTS
|
-478.86 | - | -34.28 % | $ 263 K | ||
|
Biodesix
BDSX
|
-205.65 | $ 15.46 | -0.26 % | $ 2 B | ||
|
Biocept
BIOC
|
-362.16 | - | -13.05 % | $ 7.29 M | ||
|
Invitae Corporation
NVTA
|
-98.02 | - | - | $ 21.2 M | ||
|
BioNano Genomics
BNGO
|
-316.66 | $ 1.12 | - | $ 1.42 M | ||
|
Quest Diagnostics Incorporated
DGX
|
13.84 | $ 208.13 | -0.11 % | $ 23.1 B | ||
|
Danaher Corporation
DHR
|
6.88 | $ 204.09 | 0.02 % | $ 145 B | ||
|
Organovo Holdings
ONVO
|
-23.71 | - | -2.3 % | $ 19.4 M | ||
|
Exact Sciences Corporation
EXAS
|
-8.66 | $ 103.35 | -0.02 % | $ 19.5 B | ||
|
Bioventus
BVS
|
-90.0 | $ 8.62 | -1.37 % | $ 540 M | ||
|
DarioHealth Corp.
DRIO
|
-102.21 | $ 10.3 | - | $ 292 M | ||
|
DexCom
DXCM
|
30.46 | $ 71.8 | -1.75 % | $ 28 B | ||
|
PerkinElmer
PKI
|
3.33 | - | -0.91 % | $ 14.7 B | ||
|
Psychemedics Corporation
PMD
|
-62.26 | - | -1.84 % | $ 15.3 M | ||
|
IDEXX Laboratories
IDXX
|
65.99 | $ 632.85 | -0.42 % | $ 50.9 B | ||
|
Illumina
ILMN
|
-51.54 | $ 130.71 | 0.89 % | $ 20.8 B | ||
|
QIAGEN N.V.
QGEN
|
2.34 | - | - | $ 10.6 B | ||
|
Quotient Limited
QTNT
|
312.05 | - | -11.32 % | $ 1.1 M | ||
|
ICON Public Limited Company
ICLR
|
8.31 | $ 108.37 | -0.3 % | $ 8.94 B | ||
|
Renalytix AI plc
RNLX
|
425.97 | - | 5.66 % | $ 22.7 M | ||
|
CareDx, Inc
CDNA
|
-7.05 | $ 18.76 | -0.21 % | $ 1 B | ||
|
Chembio Diagnostics
CEMI
|
-130.86 | - | 0.22 % | $ 16.8 M | ||
|
Check-Cap Ltd.
CHEK
|
1734.41 | - | - | $ 9.42 M | ||
|
Guardant Health
GH
|
419.18 | $ 93.57 | 0.28 % | $ 11.7 B | ||
|
Laboratory Corporation of America Holdings
LH
|
10.17 | $ 281.62 | -0.51 % | $ 23.4 B | ||
|
Lantheus Holdings
LNTH
|
21.43 | $ 78.82 | -0.03 % | $ 5.32 B | ||
|
IQVIA Holdings
IQV
|
20.91 | $ 175.43 | 0.82 % | $ 30.2 B | ||
|
Brainsway Ltd.
BWAY
|
-27.43 | $ 12.09 | 4.27 % | $ 99.4 M | ||
|
Co-Diagnostics
CODX
|
-41.08 | - | - | $ 79.8 M | ||
|
Mettler-Toledo International
MTD
|
-3677.41 | $ 1 316.93 | 0.07 % | $ 27.1 B | ||
|
Myriad Genetics
MYGN
|
-99.43 | $ 5.32 | 0.47 % | $ 493 M |